Kronos Bio, Inc. Additional Paid in Capital
Kronos Bio, Inc. had Additional Paid in Capital of $683.05 million as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2025-05-08
- 2025-03-31: Additional Paid in Capital $683.05M.
- 2024-12-31: Additional Paid in Capital $682.45M.
- 2024-09-30: Additional Paid in Capital $680.17M.
- 2024-06-30: Additional Paid in Capital $678.14M.
| Period end | Additional Paid in Capital |
|---|---|
| 2025-03-31 | $683.05M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $682.45M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $680.17M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $678.14M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $675.78M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $667.86M 10-K · filed 2025-03-18 |
| 2023-09-30 | $662.36M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $655.92M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $648.33M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $641.42M 10-K · filed 2024-03-21 |
| 2022-09-30 | $633.09M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $625.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $616.38M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $608.06M 10-K · filed 2023-03-15 |
| 2021-09-30 | $599.61M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $591.09M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $583.22M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $577.39M 10-K · filed 2022-02-24 |
| 2020-09-30 | $2.42M 10-Q · filed 2020-11-18 |
| 2019-12-31 | $271.00K 10-K · filed 2021-03-23 |